Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection

We recently reported on a series of patients who experienced acute cellular rejection (ACR) during the treatment of hepatitis C virus (HCV) infection in our posttransplantation cohort. Our hypothesis is that HCV clearance improves hepatic microsomal function, which in turn results in lower trough cy...

Ausführliche Beschreibung